NCT07800156

Brief Summary

The purpose of this study is to investigate the effects of an acute aerobic exercise on irisin, klotho, sirtuin-1, and BDNF levels in the healthy adults. The findings will help understand the physiological impacts of exercise on these biomarkers.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Sep 2026May 2027

First Submitted

Initial submission to the registry

August 28, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

September 2, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2027

Last Updated

September 2, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 28, 2026

Last Update Submit

August 28, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Salivary Irisin Level

    Irisin concentration will be determined from a saliva sample using the ELISA technique.

    Baseline- immediately after exercise and 1 hours after exercise

  • Salivary Klotho Level

    Klotho concentration will be determined from a saliva sample using the ELISA technique.

    Baseline- immediately after exercise and 1 hours after exercise

  • Salivary Sirtuin Level

    Sirtuin concentration will be determined from a saliva sample using the ELISA technique.

    Baseline- immediately after exercise and 1 hours after exercise

  • Salivary BDNF Level

    BDNF concentration will be determined from a saliva sample using the ELISA technique.

    Baseline- immediately after exercise and 1 hours after exercise

Secondary Outcomes (1)

  • Saliva Flow Rate

    Baseline- İmmediately after exercise and 1 hour after exercise

Study Arms (2)

Experimental Group

EXPERIMENTAL

Aerobic exercise

Behavioral: Aerobic exercise

Control Group

NO INTERVENTION

No exercise

Interventions

Acute aerobic exercise until exhaustion

Experimental Group

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being between the ages of 18 and 45
  • Being in good health and having no diagnosis of any chronic disease
  • Not having taken regular medication within the last 4 weeks
  • Voluntary participation and providing written informed consent

You may not qualify if:

  • Individuals with a history of cardiovascular, endocrine, metabolic, or renal disease
  • Individuals with a history of active infection, musculoskeletal injury, or severe disability
  • Individuals with any medical condition that might prevent participation in exercise
  • Individuals unable to regularly participate in the exercise protocol throughout the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep University Faculty of Sports Sciences

Gaziantep, Sehitkamil, 85142, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Cemre Didem Eyipınar, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

August 28, 2026

First Posted

September 2, 2026

Study Start

September 2, 2026

Primary Completion (Estimated)

April 2, 2027

Study Completion (Estimated)

May 2, 2027

Last Updated

September 2, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations